FFA
GILD icon

Fi3 Financial Advisors’s Gilead Sciences GILD Stock Holding History

Fi3 Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$701K Buy
9,091
+6,096
+204% +$803K 0.17% 63
2026
Q1 		$417K Buy
2,995
+446
+17% +$62.5K 0.12% 91
2025
Q4 		$313K Buy
2,549
+271
+12% +$32.9K 0.1% 123
2025
Q3 		$253K Sell
2,278
-180
-7% -$20.5K 0.09% 119
2025
Q2 		$273K Buy
2,458
+3
+0.1% +$319 0.1% 107
2025
Q1 		$275K Buy
2,455
+69
+3% +$7.12K 0.11% 88
2024
Q4 		$220K Buy
+2,386
New +$215K 0.08% 110

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fi3 Financial Advisors's GILD Position: Q2 2026 in Review

Fi3 Financial Advisors increased its Gilead Sciences (GILD) stake by 204% in Q2 2026, buying an estimated $803K and bringing the position to 9,091 shares worth $701K. The position accounts for 0.17% of the portfolio, ranked #63.

Fi3 Financial Advisors first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fi3 Financial Advisors held 9,091 shares of Gilead Sciences worth $701K as of Q2 2026.
  • Fi3 Financial Advisors bought 6,096 Gilead Sciences shares in Q2 2026, an estimated $803K.
  • Gilead Sciences made up 0.17% of Fi3 Financial Advisors's portfolio in Q2 2026, its #63 holding.
  • Fi3 Financial Advisors first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fi3 Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.